Severe, persistent pain in the upper abdomen — often boring through to the back — with nausea and vomiting that will not stop. That is the pancreatitis pattern.
Stop and seek medical assessment. Persistent vomiting also dehydrates and strains the kidneys — sip fluids.
Unrelenting abdominal pain, repeated vomiting, or signs of dehydration → urgent care or ER. And tell any anaesthetist before surgery: these drugs slow stomach emptying and raise the risk of aspiration under anaesthesia.
Allergic reaction: hives, swelling of the lips, tongue or throat, wheezing or dizziness can escalate to anaphylaxis within minutes — call 911 immediately. Site infection: spreading redness, heat, swelling, pus or fever is not wait-and-see; an abscess or cellulitis can need drainage or IV antibiotics. Unverified product: grey-market vials are frequently mislabelled or contaminated, so a reaction may be to endotoxin or the wrong contents, not the named compound.
The original. Exenatide is a synthetic version of exendin-4, a peptide isolated from the venom of the Gila monster, which shares roughly 53% sequence identity with human GLP-1 and — crucially — resists DPP-4 cleavage naturally. Its discovery is the reason this entire drug class exists: it demonstrated that a degradation-resistant GLP-1 receptor agonist was pharmacologically viable.
First-in-class, approved in 2005. Superseded in potency and convenience by later agents, and now of more historical than clinical interest, but the trial base is long-established.
FDA-approved for type 2 diabetes. Prescription-only. Some formulations have been discontinued commercially.
Boxed warning on the extended-release formulation for rodent thyroid C-cell tumours. Pancreatitis signal. Renal impairment cautions. Physician supervision required.
Byetta: 5–10 mcg twice daily SC. Bydureon: 2 mg once weekly SC. FDA-label regimens.
Reported from clinical trials or FDA labelling as a matter of record. It is not a recommendation, and for unapproved compounds no dose has been shown safe or effective in humans.
Above is what was administered in trials or on FDA labels, reported as fact. We do not convert it into a personal protocol, calculate a dose for your body weight, or tell you what to inject or how to reconstitute it — that decision belongs with a licensed physician. See our editorial policy.
Regulatory status changes. This page reflects our reading of public sources as of July 2026 and should be independently verified before it is relied upon.